‹ View All Resources

Case Study: CareMetx Omnichannel Program Drives Initiation and Persistence for a Self-Injectable Rheumatology Biologic

Case Study

Self-injectable drugs help patients manage chronic conditions from the convenience of
home, yet they’re more complicated to administer than oral drugs, creating barriers for
patients to initiate and stay on therapy. Patients with a chronic inflammatory disease
can encounter obstacles throughout the care journey—from poor health and low literacy
before the diagnosis, to anxiety about the injection process once they receive a RX, to
lack of motivation and side effects concerns throughout their therapy.

Read the Case Study

Download the case study PDF to read more